Want to create an interactive transcript for this episode?
Podcast: Pharmacy Podcast Network
Episode: Insights into the (GCT) Gene/Cell Therapy market & challenges facing market entrants and commercialization | Ascella Health
Description:
Continuing advances in cell and gene therapy (CGT) are transforming the pharmacy and point of care ecosystem. Recent launches of new CGTs have yielded mixed results on getting the right therapy to the right patients. The CGTs pipeline and approvals are likely to rise dramatically in the near future. In 2024 alone, up to 21 cell therapy launches and as many as 31 gene therapy launches are on the horizon. Therefore, the launch readiness for these products should be effective so that the therapies can benefit as many patients as possible while ensuring a sufficient return on manufacturers’ investments. With so many new CGT...